Pivekimab Sunirine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Pivekimab Sunirine. Educational only — not medical advice.
Labeled uses
DECNUPAZ is indicated for the treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Source: FDA labeling via NIH DailyMed (set 508b6ff8…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.